ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Genzyme has agreed to sell its Genzyme Genetics testing services business, which had revenues of $370 million in 2009, to Laboratory Corporation of America for $925 million. The sale is part of a five-year plan that Genzyme announced in May to find alternatives for three noncore units. It is trying to strengthen its business in the face of near-devastating manufacturing problems and after rejecting a takeover offer from Sanofi-Aventis. In addition to the sale, Genzyme will also cut 1,000 jobs over 15 months to reduce operating costs.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X